Patent · US Expired

Oxadiazolyl imidazobenzodiazepine derivatives pharmaceutical compositions thereof, and method of treating therewith

US4670433A · kind A · utility

4Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 1986
Grant dateJun 2, 1987
Priority date
Expiry dateMar 6, 2006

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

New oxadiazolyl imidazobenzodiazepine derivatives having the formula ##STR1## wherein R.sup.3 has the formula ##STR2## wherein R" is hydrogen, C.sub.1-6 alkyl C.sub.1-6 alkoxymethyl or C.sub.3-6 - cycloalkyl; PA0 R.sup.4 is hydrogen; PA0 R.sup.5 is C.sub.1-6 alkyl or R.sup.4 and R.sup.5 together form a 2-4 membered alkylene bridge; and R.sup.A is C.sub.1-6 alkyl, C.sub.1-6 alkoxy, or C.sub.1-3 trifluoroalkyl, pharmaceutical compositions thereof, and method of treating therewith, are disclosed. The compounds and pharmaceutical compositions are useful in the amelioration, mitigation, or elimination of central nervous system disorders related to benzodiazepine receptors and especially as anticonvulsants, anxiolytics, hypnotics, and nootropics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.